Perspective Therapeutics (CATX) Gross Margin Growth (3y) (2013 - 2023)
Perspective Therapeutics (CATX) Gross Margin Growth (3y) (2013 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 63.00 |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 17.00 |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -136.00 |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 15.00 |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -324.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 311.00 |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 56.00 |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -164.00 |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 124.00 |
| 10 | Perspective Therapeutics | 308.74 Mn | 308.74 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -4,867.00 |
| Sep 30, 2023 | -1,849.00 |
| Jun 30, 2023 | -3,046.00 |
| Mar 31, 2023 | -3,262.00 |
| Sep 30, 2022 | -2,928.00 |
| Jun 30, 2022 | -872.00 |
| Mar 31, 2022 | 383.00 |
| Dec 31, 2021 | 315.00 |
| Sep 30, 2021 | 659.00 |
| Jun 30, 2021 | 2,203.00 |
| Mar 31, 2021 | 1,367.00 |
| Dec 31, 2020 | 1,490.00 |
| Sep 30, 2020 | 3,038.00 |
| Jun 30, 2020 | 1,064.00 |
| Mar 31, 2020 | 3,638.00 |
| Dec 31, 2019 | 5,046.00 |
| Sep 30, 2019 | 4,895.00 |
| Jun 30, 2019 | 4,997.00 |
| Mar 31, 2019 | 4,018.00 |
| Dec 31, 2018 | 3,766.00 |